Aerpio Pharmaceuticals, Inc.
Methods of treating intraocular pressure with activators of Tie-2

Last updated:

Abstract:

Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions associated with angiogenesis, for example, intraocular pressure, ocular hypertension, and glaucoma.

Status:
Grant
Type:

Utility

Filling date:

22 Sep 2016

Issue date:

23 Mar 2021